Background: Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal growth; however, the downstream regulatory mechanisms remain unclear. In this study, we investigated whether BDNF exerts its neurotrophic effects through the Wnt/β-catenin signaling pathway in human embryonic spinal cord neurons in vitro. Methods: The research was carry out by human embryonic spinal cord neurons cultured in vitro, immunofluoresence labelling, BDNF plasmid transfection and siRNA interference, RT-PCR, Real time quantitative PCR and Western Blot. Results: We found that neuronal growth (soma size and average neurite length) was increased by transfection with a BDNF overexpression plasmid. Western blotting and real-time quantitative PCR showed that expression of the BDNF pathway components TrkB, PI3K, Akt and PLC-γ were increased by BDNF overexpression. Furthermore, the Wnt signaling factors Wnt, Frizzled and Dsh and the downstream target β-catenin were upregulated, whereas GSK-3β was downregulated. In contrast, when BDNF signaling was downregulated with BDNF siRNA, the growth of neurons was decreased. Furthermore, BDNF signaling factors, Wnt pathway components and β-catenin were all downregulated, whereas GSK-3β was upregulated. Then we treated neurons with 6-bromoindirubin-3'-oxime (BIO), a small molecule GSK-3β inhibitor. BIO reduced the effects of BDNF upregulation/downregulation on soma size and average neurite length, and suppressed the impact of BDNF modulation on the Wnt signaling pathway. Conclusions: Our findings suggest that BDNF promotes the growth of neurons in vitro through crosstalk with the Wnt/β-catenin signaling pathway, and that this interaction may be mediated by GSK-3β.
Spinal cord injury (SCI) severely impacts the physical, psychological and social well-being of patients, and places a serious financial burden on health care systems. However, there is as yet no effective clinical treatment. A major hurdle for the development of effective therapeutic strategies is the lack of significant neuronal regeneration following injury [1, 2] . Critical for the effective repair of the injured spinal cord is enhancing the survival of damaged cells and encouraging the regrowth of severed axons [2] . Recent studies show that neurotrophic factors are critical for synaptic plasticity, neuronal regeneration, axonal growth, and functional recovery following SCI [3] . Brain-derived neurotrophic factor (BDNF) is involved in neuronal proliferation, development, differentiation and maturation [4] . Previous studies demonstrated that BDNF can enhance the survival of cultured toad embryonic spinal cord neurons, promote the growth of neurites, and act as a morphogenetic and tropic factor [5, 6] . A recent study showed that BDNF plays a very important role in the differentiation and maturation of progenitor cells in the subgranular zone of the dentate gyrus [7] . BDNF promote motility in an N-methyl-D-aspartate (NMDA)/gamma-aminobutyric acid (GABA)-responsive subset of neural progenitor cells (NPCs) [8] . Furthermore, BDNF can also promote the recovery of motor function following SCI by transplanting the neural stem cells (NSCs) with high BDNF expression into injured brain tissue [9] . BDNF has been shown to have numerous and varied effects on the nervous system. Application of an anti-BDNF antibody reduces neuroma formation following nerve transection, without inhibiting axon regeneration [10] . Low levels of BDNF in the hippocampus appear to be associated with cognitive impairment during sepsis [11] . In addition, BDNF is one of the most important modulators of glutamatergic and GABAergic synapses and plays a major role in synaptic plasticity [12] . However, the molecular mechanisms involved in neuronal growth and differentiation are still not fully understood.
RESEARCH HIGHLIGHT
It is well known that the Wnt/β-catenin signaling pathway is crucial to the survival, growth and differentiation of neurons. A recent study reported that Wnt/β-catenin signaling modulation can improve cell replacement therapy for Parkinson's disease [13] . Wnt/β-catenin signaling can also regulate hippocampus neurogenesis, and Wnt knockout mice showed midbrain loss [14] . The Wnt/β-catenin pathway can also regulates oligodendrocyte development by a stage-dependent manner [15] . Aging inhibited Wnt signaling, whereas β-catenin activation in situ with a specific GSK-3β antagonist promoted a significant degree of dopaminergic neurorestoration associated with reversal of motor deficit, with implications for neurorestorative approaches in Parkinson's disease [16] . There are also reports that BDNF and Wnt signaling cooperate to exert their biological functions, such as in the regulation of dendritic spine formation [17] . A previous study reported that BDNF can functionally cross-talk with Wnt/β-catenin signaling in mice neuronal stem cells [18] .
Despite the numerous roles of BDNF in neuronal growth and differentiation, the underlying molecular mechanisms remain unclear. Furthermore, it is not known how the BDNF and Wnt signaling pathways interact to exert their biological functions. In this study, we investigated the effect of BDNF on the cultured neurons which derived from human embryonic spinal cord and the relationship between BDNF and Wnt/β-catenin signaling pathway.
In summary, we found the relationship between the BDNF and Wnt signaling pathways and the changes in BDNF and Wnt signaling factors induced by BDNF modulation and BIO treatment as shown in Figure1 [19] . There are three major novel findings in this study. First, we found that BDNF promotes the growth of human embryonic spinal cord neurons. Second, BDNF is a strong regulator of Wnt signaling in neurons, revealing crosstalk between the two pathways. Third, the regulatory effect of BDNF is suppressed by GSK-3β inhibition. Our study is the first to report on the molecular mechanisms underlying the BDNF promote of cellular development, and the relationship with Wnt/β-catenin signaling pathway in cultured human embryonic spinal cord neurons. A better understanding of the molecular interactions between the BDNF and Wnt cascades may help in the development of therapeutic strategies for neurological disorders.
